Receptor for Advanced-Glycation End Products | Zendy

Loredana Bucciarelli | Zendy; Michiyo Kaneko | Zendy; Radha Ananthakrishnan | Zendy; Evis Harja | Zendy; Larisse K. Lee | Zendy; Yuying C. Hwang | Zendy; Shulamit Lerner | Zendy; Soliman A. Bakr | Zendy; Qing Li | Zendy; Yan Lü | Zendy; Fei Song | Zendy; Wu Qu | Zendy; Teodoro Gomez | Zendy; Yu Zou | Zendy; Shi Fang Yan | Zendy; Ann Marie Schmidt | Zendy; Ravichandran Ramasamy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Receptor for Advanced-Glycation End Products

Author(s) -

Loredana Bucciarelli,

Michiyo Kaneko,

Radha Ananthakrishnan,

Evis Harja,

Larisse K. Lee,

Yuying C. Hwang,

Shulamit Lerner,

Soliman A. Bakr,

Qing Li,

Yan Lü,

Fei Song,

Wu Qu,

Teodoro Gomez,

Yu Zou,

Shi Fang Yan,

Ann Marie Schmidt,

Ravichandran Ramasamy

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.575993

Subject(s) - rage (emotion) , glycation , medicine , context (archaeology) , nitric oxide , adenosine , nitrotyrosine , ischemia , reperfusion injury , cyclic guanosine monophosphate , receptor , nitric oxide synthase , endocrinology , biology , neuroscience , paleontology

The beneficial effects of reperfusion therapies have been limited by the amount of ischemic damage that occurs before reperfusion. To enable development of interventions to reduce cell injury, our research has focused on understanding mechanisms involved in cardiac cell death after ischemia/reperfusion (I/R) injury. In this context, our laboratory has been investigating the role of the receptor for advanced-glycation end products (RAGE) in myocardial I/R injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research